Artisan Partners
YMAB

Artisan Partners’s Y-mAbs Therapeutics YMAB Stock Holding History

Artisan Partners’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,581,845
Closed -$25.6M – 353
2021
Q4 		$25.6M Sell
1,581,845
-106,711
-6% -$2.28M 0.03% 292
2021
Q3 		$48.2M Buy
1,688,556
+370,277
+28% +$11.7M 0.06% 243
2021
Q2 		$44.6M Buy
1,318,279
+379
+0% +$12.2K 0.05% 249
2021
Q1 		$39.9M Buy
1,317,900
+270,484
+26% +$11.1M 0.05% 269
2020
Q4 		$51.9M Buy
1,047,416
+321,788
+44% +$14.9M 0.06% 247
2020
Q3 		$27.9M Buy
725,628
+99,362
+16% +$3.95M 0.04% 265
2020
Q2 		$27.1M Buy
626,266
+79,626
+15% +$3.01M 0.04% 243
2020
Q1 		$14.3M Buy
+546,640
New +$15.9M 0.03% 252

Other funds holding YMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Artisan Partners's YMAB Position: Q1 2022 in Review

Artisan Partners sold out of Y-mAbs Therapeutics (YMAB) in Q1 2022, closing a stake of 1,581,845 shares — an estimated $25.6M sold.

Artisan Partners first reported a position in YMAB in Q1 2020 and held it in 8 quarters. The position peaked at $51.9M in Q4 2020. 88 funds tracked by Wall St. Rank hold YMAB as of Q1 2022.

  • Artisan Partners reported no remaining Y-mAbs Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Artisan Partners sold 1,581,845 Y-mAbs Therapeutics shares in Q1 2022, an estimated $25.6M.
  • Artisan Partners first reported a position in Y-mAbs Therapeutics in Q1 2020 and held it in 8 quarters.
  • Artisan Partners's Y-mAbs Therapeutics position peaked at $51.9M in Q4 2020.
  • 88 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q1 2022.

Based on Artisan Partners's 13F filing for Q1 2022, filed 13 May 2022.